Evaluating the effect of vitamin D supplementation on different stages of blood pressure

Phase 3

Recruiting

• Conditions: Hypertension.; Essential (primary) hypertension

• Registration Number: IRCT20190819044565N1
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 116

Inclusion Criteria

Age range 18 years and above
Interested in attending a study that filled out an informed consent form
Hypertensive patients with systolic blood pressure above 140 and diastolic blood pressure above 90 with identical conditions and approved by the cardiologist in the study
Serum vitamin D levels less than 30 ng/dl
People who use only the following four drugs to control their blood pressure1Angiotensin Inhibitors (Losartan, Captopril, Valsartan)2 Calcium channel blockers (amlodipine, diltiazem)3Inhibitors of beta-adrenergic receptors (ethnolol, metoprolol, bisoprolol (concur))4Diuretics (hydrochlorothiazide, triamterene)

Exclusion Criteria

Mental, emotional, cognitive disorders
People under 18 years
People with secondary hypertension
Specific dietary restrictions
Pregnant women
Nonsteroidal anti-Inflammatory drugs or glucocorticoids
Disease that requires chemotherapy or radiation
Consumption of bisphosphonates, including alendronate, alendronate and rhizdronate
Use of anticonvulsant drugs (including phenytoin, phenobarbital, primidone, carbamazepine, x carbazepine, valproic acid, clonazepam)
Use of antihyperlipidemic diarrhea medications including cholestyramine
Alcohol consumption
Consumption of radioactive iodine or any radiation
Oral or injectable corticosteroids (including prednisone, prednisilone, dexamethasone, triaxinolone, hydrocortisone or beta-metazone)
Kidney diseases
Calcium supplements
Lactating women
Coeliac disease
Crohn's disease
Ulcerative colitis
Steatorrhea
Biliary problems
Potassium supplementation
Magnesium Supplementation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Stages of blood pressure. Timepoint: at baseline (before intervention) and end of study (after 14 weeks). Method of measurement: Ambulatory Blood Pressure Monitoring, millimeter mercury.